Axign, now part of Monolithic Power Systems (MPS), is moving from amplifier-controller ICs and reference designs to a new family of integrated, production-ready Class-D amplifier modules. The strategy ...
HLP003 has been granted Breakthrough Therapy Designation by the FDA, which makes HLP003 eligible for an expedited review pathway, with the potential to reduce drug development timelines. Helus Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results